The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients
Company to launch product after the expiry of semaglutide patent in India
DME is among the most challenging retinal diseases to treat and has long served as a proving ground for therapies that ultimately become first-line standard of care in retinal diseases
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
Subscribe To Our Newsletter & Stay Updated
